SMS Pharmaceuticals Ltd share price logo

SMS Pharmaceuticals Ltd

NSE: SMSPHARMA

BSE: 532815

Small Cap

Pharma Sector

₹406.60

-3.55

(-0.87%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with SMS Pharmaceuticals shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+129%

Searches for SMS Pharmaceuticals on INDmoney have increased by 129% over the last 30 days.

Investment activity on INDmoney

+310.59%

Investment activity in SMS Pharmaceuticals among INDmoney users has increased by 310.59% over the last 30 days.

Among the most traded stocks

481st

SMS Pharmaceuticals was the 481st most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

21 days

INDmoney investors hold SMS Pharmaceuticals shares for an average of 21 days.

Key Events for SMS Pharmaceuticals

Upcoming Events

Ex-Dividend Date22/09/2026
Record Date22/09/2026

Last Dividend Declared

₹0.40 per share, declared on 22/05/2026

View Dividend History

SMS Pharmaceuticals Stock Performance

as on September 16, 2026 at 6:30 pm IST

  • Day's Low

    Day's High

    ₹393.25
    ₹413.35
    downward going graph

    3.28%

    Downside

    1.66%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹242.25
    ₹469.00
    downward going graph

    40.42%

    Downside

    15.35%

    Upside

    downward going graph

SMS Pharmaceuticals share price movements today

Previous Close
₹410.15
Open
₹404.00
Volume
5.66L
Upper Circuit
₹492.15
Lower Circuit
₹328.15
Day's Low - High
₹393.25 - ₹413.35
52 Week Low - High
₹242.25 - ₹469.00

SMS Pharmaceuticals Historical Returns

1 Month Return
+ 14.54 %
3 Month Return
+ 8.97 %
1 Year Return
+ 43.66 %
3 Year Return
+ 229.04 %
5 Year Return
+ 156.02 %

SMS Pharmaceuticals Fundamentals

as on September 16, 2026 at 1:00 pm IST

Market Cap

₹3,841.14 Cr

Return on Equity (ROE)

11

PE Ratio (TTM)

41.23

Return on capital employed (ROCE)

12.18

Industry PE ratio

51.81

Beta (LTM)

1.19

P/B Ratio

2.87

Dividend Yield

0.19

PEG Ratio

15.21

Quarterly Earnings Growth YOY

7.96

EPS (TTM)

7.6

Book Value

70.36

SMS Pharmaceuticals Stock Valuation

as on September 16, 2026 at 1:00 pm IST

SMS Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-163.97x)

June 20, 2023

Today (41.23x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (2093.00x)

November 11, 2022

LowHigh

Today’s Price to Earnings Ratio: 41.23x

SMS Pharmaceuticals Technical Analysis

Track how SMS Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish4
Bullish9
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
1.14
Bearish
CCI (20)
-140.72
Bullish
RSI (14)
55.36
Neutral
Momentum (10)
-0.3
Bullish
ADI (14)
42.19
Bearish
Ultimate Oscillator (7,14,28)
61.39
Neutral

Moving Averages

Name

Value

Action

SMA (20)
406.68
Bearish
EMA (20)
406.32
Bullish
VWMA (20)
407.05
Bearish
SMA (50)
403.22
Bullish
EMA (50)
404.08
Bullish
SMA (200)
400.19
Bullish
EMA (200)
401.9
Bullish
KAMA (200)
404.91
Bullish
DEMA (200)
400.81
Bullish

SMS Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of SMS Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
SMS Pharmaceuticals Ltd image
SMS Pharmaceuticals Ltd
BUY3,841.1431.2%0.6667782
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Market expectation of SMS Pharmaceuticals Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

SMS Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
166.64
161.48
245.8
164.45
196.75
173.35
248.2
196.05
242.43
210.45
237.95
206.96
Other Income
0.81
1.49
1.65
1.37
1.3
2.13
1.42
0.59
1.43
3.75
2.57
1.74
Total Income
167.45
162.97
247.44
165.82
198.05
175.48
249.62
196.64
243.86
214.2
240.52
208.71
Expenses
138.82
132.48
212.18
130.94
165.28
140.14
207.39
156.68
194.06
166.8
198.05
166.01
Operating Profit
27.82
29
33.62
33.51
31.47
33.21
40.81
39.37
48.37
43.65
39.9
40.95
Operating Profit Margin %
16.69%
17.96%
13.68%
20.38%
15.99%
19.16%
16.44%
20.08%
19.95%
20.74%
16.77%
19.79%
Profit Before Interest, Tax and Depreciation
28.63
30.49
35.26
34.88
32.77
35.34
42.23
39.96
49.8
47.4
42.47
42.7
Interest
5.57
5.95
5.61
4.67
4.61
4.2
5.07
5.84
5.74
6.22
5.28
5.5
Depreciation
7.9
8.01
7.92
8.38
8.62
8.7
8.64
9.75
10.02
10.02
10.13
9.99
Profit Before Tax
15.16
16.53
21.73
21.83
19.54
22.44
28.52
24.37
34.04
31.16
27.06
27.21
Tax Paid
3.11
4.24
5.69
5.46
5.68
5.36
8.44
5.65
8.91
7.97
6.1
7
Profit After Tax
12.05
12.29
16.05
16.37
13.86
17.08
20.08
18.71
25.13
23.19
20.96
20.2
Total Net profit including share of profit / Loss from associate company
11.73
11.48
17.28
16.47
14.1
18.24
20.31
20.49
25.31
23.47
32.71
20.91
EPS
1.39
1.36
2.04
1.95
1.67
2.15
2.4
2.31
2.84
2.59
3.58
2.23
Actual EPS
1.39
1.36
2.04
1.95
1.67
2.15
2.4
2.31
2.84
2.59
3.58
2.23
Adjusted EPS
1.39
1.36
2.04
1.95
1.67
2.15
2.4
2.31
2.84
2.59
3.58
2.23
Diluted EPS
1.39
1.36
2.04
1.95
1.67
2.15
2.4
2.31
2.84
2.59
3.58
2.23

SMS Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
462.68
464.91
411.95
563.18
519.87
522.05
709.26
782.75
886.87
Other Income
2.39
3.4
5.11
3.45
5.2
4.91
4.46
6.22
8.35
Total Income
465.06
468.31
417.06
566.63
525.07
526.97
713.72
788.97
895.22
Expenses
369.34
374.81
332.03
442.07
405.55
467.58
592.64
643.76
715.59
Operating Profit
93.34
90.1
79.92
121.11
114.32
54.47
116.62
138.99
171.28
Operating Profit Margin %
20.17%
19.38%
19.4%
21.5%
21.99%
10.43%
16.44%
17.76%
19.31%
Profit Before Interest, Tax and Depreciation
95.73
93.5
85.03
124.56
119.53
59.39
121.08
145.22
179.63
Interest
15.48
11.87
12.21
11.16
18.88
21.91
23.46
18.54
23.08
Depreciation
19.9
19.27
22.07
22.28
32.15
32.13
31.52
34.34
39.92
Profit Before Tax
60.35
62.36
50.75
91.12
68.5
5.35
66.1
92.34
116.63
Tax Paid
19.89
20.9
18.07
30.16
0.62
1.47
16.91
24.94
28.64
Profit After Tax
40.45
41.45
32.69
60.96
67.88
3.88
49.2
67.4
88
Total Net profit including share of profit / Loss from associate company
31.75
40.04
31.58
62.52
62.22
-7.06
49.83
69.14
101.99
EPS
3.75
4.73
3.73
7.39
7.35
-0.83
5.89
8.16
11.15
Actual EPS
3.75
4.73
3.73
7.39
7.35
-0.83
5.89
8.16
11.15
Adjusted EPS
3.75
4.73
3.73
7.39
7.35
-0.83
5.89
8.16
11.15
Diluted EPS
3.75
4.73
3.73
7.39
7.35
-0.83
5.89
8.16
11.15

SMS Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
61.22
73.47
31.81
49.76
39.71
90.45
45.06
22.45
50.12
81.71
Cash Flow from Investing Activities
-96.72
-39.26
-16.58
-34.68
-42.56
-151.6
-27.15
-29.76
-52.07
-123.42
Cash Flow from Financing Activities
26.65
-33.19
-14.89
-12.92
-2.4
92.03
-11.76
-31.97
30.69
47.07
Net Cash Flow
-8.84
1.03
0.35
2.17
-5.25
30.88
6.16
-39.28
28.73
5.36

SMS Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
64.32%
64.67%
64.67%
64.67%
64.67%
66.26%
66.26%
68.07%
68.07%
68.07%
68.07%
DII
0%
1.98%
2.13%
2.55%
2.55%
2.43%
3.03%
2.88%
3.21%
3.02%
2.83%
FII
0.59%
0.17%
0.17%
0.52%
0.31%
0.08%
0.03%
0.28%
0.04%
0.31%
0.65%
Public
35.09%
33.17%
33.03%
32.26%
32.47%
31.22%
30.67%
28.78%
28.69%
28.6%
28.45%
Total Outstanding Shares
8,46,52,030
8,46,52,030
8,46,52,030
8,46,52,030
8,46,52,030
8,86,52,030
8,86,52,030
9,36,52,030
9,36,52,030
9,36,52,030
9,36,52,030
Total Shareholders
25,341
30,140
31,780
33,136
34,973
35,332
33,652
34,157
34,378
32,397
31,489

Mutual Funds Buying / Exiting SMS Pharmaceuticals

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying SMS Pharmaceuticals

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Bandhan BSE Healthcare Index Fund Direct Growth

Bandhan BSE Healthcare Index Fund Direct Growth

₹0.02 Cr

₹0.00 Cr (+7.42%)

0.07%

Mutual Funds Exiting SMS Pharmaceuticals

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

SMS Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of SMS Pharmaceuticals.

  • SMS Pharmaceuticals Ltd Earnings Results

    SMS Pharmaceuticals Ltd’s net profit jumped 2.05% since last year same period to ₹20.91Cr in the Q1 2026-2027. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated -36.07% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • SMS Pharmaceuticals Ltd Dividends May,2026

    In the quarter ending March 2026, SMS Pharmaceuticals Ltd has declared dividend of ₹0.40 per share on 22 May 2026 - translating a dividend yield of 0.17%.

    Read More about Dividends

Indices Featuring SMS Pharmaceuticals Stock

Check stock indices that include SMS Pharmaceuticals.

BSE Healthcare

₹50,316.56

-162.25 (▲0.32%)

Insights on SMS Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, SMSPHARMA stock has moved up by 229.0%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SMSPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.31% to 0.65% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 7.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.07% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 32.71 Cr → 20.91 Cr (in ₹), with an average decrease of 36.1% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 28.60% to 28.45% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 240.52 Cr → 208.71 Cr (in ₹), with an average decrease of 13.2% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 2.96% to 2.81% in Jun 2026 quarter

About SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Limited is a public company founded in December 1987. Focused on manufacturing Active Pharmaceutical Ingredients and intermediates, the company has two facilities in Hyderabad and one in Vijayanagaram Dist. During 2015, the company successfully completed US FDA audits, filed nine Drug Master Files, and became an associate company of M/s. VKT Pharma Private Limited by acquiring 1,225,900 equity shares. During 2016-17, the company also acquired 511,400 shares in Sireen Drugs Private Limited and invested in SMS Lifesciences India Limited. 2017-18 saw the Scheme of Arrangement between Demerged and Resulting Companies, approved by Hon’ble National Company Law Tribunal and investment of 784,100 equity shares in VKT Pharma PVT LTD. In FY 2018-19, the company had 38,501,65 equity shares in VKT Pharma PVT LTD.

Revenue: ₹206.96Cr as on June 2026 (Q1 FY27)
Net Profit: ₹20.20Cr as on June 2026 (Q1 FY27)
Listing date: 28 Feb, 2007
Chairperson Name: P Ramesh Babu
OrganisationSMS Pharmaceuticals Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOP Ramesh Babu
E-voting on sharesClick here to vote

FAQs

What is SMS Pharmaceuticals share price today?

SMS Pharmaceuticals share price today stands at ₹406.6 as on . SMS Pharmaceuticals share today touched a day high of ₹413.35 and a low of ₹393.25.

What is the 52 week high and 52 week low range for SMS Pharmaceuticals share?

SMS Pharmaceuticals touched a 52 week high of ₹469 and a 52 week low of ₹242.25. SMS Pharmaceuticals share price today i.e. is trending at ₹406.6, which is -13.30% down from its 52 week high and 67.84% up from its 52 week low.

What is SMS Pharmaceuticals's market capitalisation today?

SMS Pharmaceuticals market capitalisation is ₹3,841.14 Cr as on .

How to buy SMS Pharmaceuticals shares?

To buy SMS Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SMSPHARMA or SMS Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in SMS Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is SMS Pharmaceuticals trading volume today?

SMS Pharmaceuticals trading volume is 5.66L as on . This means that 5.66L shares of SMS Pharmaceuticals were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with SMS Pharmaceuticals shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in SMS Pharmaceuticals have both increased over the past 30 days, and the average INDmoney investor holds the stock for 21 days. This reflects platform activity only and is not investment advice.